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Abstract
The Schwann cells are the myelinating glia of the peripheral nervous system that originated during
development from the highly motile neural crest. However, we do not know what the guidance
signals for the Schwann cell precursors are. Therefore, we set to test some of the known
© Springer Science+Business Media, LLC 2010
Correspondence to: Maria Elena de Bellard, maria.debellard@csun.edu.
Martha Cornejo, Deborah Nambi and Christopher Walheim these authors contributed equally.
NIH Public Access
Author Manuscript
Neurochem Res. Author manuscript; available in PMC 2012 March 12.
Published in final edited form as:
Neurochem Res. 2010 October ; 35(10): 1643–1651. doi:10.1007/s11064-010-0225-0.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
neurotrophins that are expressed early in developing embryos and have been shown to be critical
for the survival and patterning of developing glia and neurons. The goal of this study was to
determine more specifically if GDNF, NRG1 and NGF are chemoattractants and/or chemokinetic
molecules for a Schwann cell precursor line, the Spl201. We performed live chemoattraction
assays, with imaging and also presented these molecules as part of their growing substrate. Our
results show for the first time that GDNF and NRG1 are potent chemoattractive and chemokinetic
molecules for these cells while NGF is a chemokinetic molecule stimulating their motility.
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Introduction
The development of the nervous system is a fascinating process involving cell induction,
determination and movement. In the embryo, neural crest cells are amongst the most motile
and persistent, starting with a transformation from an epithelial to a mesenchymal cell in the
neural tube, to becoming a heterogeneous population that migrates quickly and extensively
throughout the early developing embryo. The neural crest gives rise to a wide variety of
cells amongst which is the peripheral glia: Schwann cells [1, 2]. Therefore, Schwann cells
derive from a population of cells that initially have stem cell properties and are highly motile
[1, 3, 4].
Developing Schwann cell precursors encounter a rich environment during their migration
into the embryo tissues [5]. Along this path they encounter signals (extracellular matrix
proteins, membrane associated as well as secreted guidance molecules) that likely guide
them to their targets [6, 7]. However, it has not been tested and proven if Schwann cell
precursors (SCPs) migrate using diffusible signals to reach their targets, as is the case with
axon elongation [8], though there are implicit indications that they do [9, 10]. First, neural
crest cells and later on, SCPs are capable of migrating in the absence of axons [10, 11].
Second, time-lapse of zebrafish labeled neural crest/SCPs showed that these cells reach their
targets without axons and even tow axons along the lateral line [12, 13]. These observations
underscore that SCPs are capable of sensing and finding independently the proper cues when
reaching their targets. Third, erbB3 receptor knockout mice and zebrafish have severe
Schwann cell development phenotypes [14–16]. Fourth, SCPs have been shown to migrate
close to growing axons in the developing limb, thus suggesting that both might be following
the same diffusible signals to their targets [9].
Despite this wealth of findings, we still do not know: (1) a single signal molecule clearly
responsible for SCP guided migration, as we know for growth cone guidance [7]. (2) If the
chemotrophic signals (neurotrophins) involved in determining the fate of SCPs are also
involved in their migration and (3) if these molecules, which provide chemotactic and
chemokinetic signals to growing axons are also capable of attracting and stimulating the
motility of Schwann cell precursors.
In order to preliminarily answer these questions we turned to a cell line with a phenotype
intermediate between neural crest and Schwann cell precursors [17, 18]. In our search for
candidate diffusible molecules, we focused on the neurotrophins already implicated in
Schwann cell development: Glia derived neurotrophic factor (GDNF), neuregulin beta-1
(NRG1) and nerve growth factor (NGF) which are expressed early in development along
paths traversed by the Schwann cell precursor and whose receptors are known to be
expressed by these cells during the period of their active migration along axons [5]. Our
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preliminary data suggests that GDNF and NRG1 are chemotactic (attractant) and
chemokinetic molecules for SCPs and that NGF has just chemokinetic effects.
Experimental Procedures
In Vitro Chemoattraction of Neurotrophins
In these experiments SpL201 (125,000) were plated on the upper side of a chemotatic
(Millipore) chamber with 200 ng/ml in the lower chamber to create a gradient steep enough
for chemotaxis [19]. After 5 h the cells on the upper side of the filter were removed and cells
on the bottom side fixed with 4% Paraformaldehyde (PFA) and stained with toluidine blue.
Cells were expanded and grown in feeding media: DMEM (Gibco), 10% fetal bovine serum,
2 mM L-glutamine, and antibiotics (Omega) plus 10 ng/ml of EGF. Two days prior to the
experiments, cells were deprived of EGF.
Time Lapse Video Microscopy
Cells were cultured on Ibidi micro-slides in DMEM/10%FBS. Next day cells were exposed
to a focal source of neurotrophin and imaged in a Zeiss 35 M at 90s intervals for 3 h [20].
The captured images were converted into an ImageJ movie and analyzed using the Ibidi
pluggin for tracking individual cells.
Micro-Chip Preparation Assay
The chips for patterning proteins are prepared by the Caltech Microfluidic Foundry
(www.kni.caltech.edu/foundry). The chips were cut out and thermally bonded at 80°C to an
epoxy coated glass slide (Arrayit Corporation) for a few hours. Connectors were inserted
then peristaltic tubing is attached and proteins in a non-reactive buffer were flown through at
low pressures (1–3 psi). After allowing for a few minutes of reaction time, the remaining
solution was flushed out with buffer. The exact amount of protein bonding to the surface can
be controlled by using a mix of the protein of interest and bovine serum albumin in different
ratios.
Micro-Chip Assay
SpL201 re-suspended in Fibronectin (100 µg/ml) were plated at 70–80% confluence over
the micro-chips coated with neurotrophins for 2 h, and then the tissue culture dish was filled
with feeding media for 3 more hours. We then took phase contrast pictures and returned
cells to incubator for 12 h. Cultures were fixed in 4% PFA and stained with toluidine blue to
visualize the cells.
Wound Assay
SpL201 cells were allowed to grow onto 90% confluence overnight and next day
monolayer’s were wound by scrapping with a pipette tip [21, 22]. Culture media was
replaced with feeding media or with media containing neurotrophins; cells were allowed to
migrate for 5hsr before fixing with 4% PFA and staining with toluidine blue. We counted at
least in 6–7 areas the number of cells that invaded the wound. Each experiment had a
duplicate and the data corresponded to 5 experiments. Experiments were done in feeding
media with 10%FBS or without any FBS.
SpL201 Injection
A cell suspension of SpL201 cells was incubated for 10 min with a 10 µM solution of DiI a
lipophillic fluorescent dye (Molecular Probes) and washed three times before being injecting
the labeled cells using a mouth micro-pipette in HH15 chicken embryos. Cells were injected
along the path were hosts neural crest cells migrate: between the neural tube and somites at
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the forelimb level. Next day embryos were fixed in 4% PFA and the forelimb portion was
cryosectioned and stained with HNK1 to label host’s neural crest cells. Immunostained
sections were mounted in permount after DAPI labeling of nuclei.
Results
Characterizing SpL201 Cell Line
The SpL201 is an immortalized Schwann cell precursor line that is capable of differentiating
into fully myelinating Schwann cells [17]. We first characterized the SpL201 mouse cell line
in order to determine the extent to which these cells correspond to a fully differentiated
Schwann cell phenotype versus a more transient cell type before carrying out any migration
assays. We found that 90% of these cells expressed classic Schwann cell precursor markers
like Sox10, GFAP, S100, p75 and RIP (Fig. 1). However, not all cells were positive for
these markers at the same time or to the same extent, underscoring that many of these cells
are still transitioning between a neural crest and a glial phenotype. Further support to this
came from looking also at these cells morphology. We never observed in these cells the
classic spindle shape of differentiated Schwann cells [18, 23].
In addition, we also injected SpL201 vitally labeled with DiI into HH15 chicken embryos to
determine their migratory capabilities in an in vivo environment. We found that these cells
migrated along typical neural crest pathways (Fig. 2). We found DiI-labeled SpL201 cells
along the ventromedial pathway, around the dorsal aorta, entering the gut (Fig. 2a and b), as
well as in the dorsomedial pathway of melanocytes (between the ectoderm and
dermomyotome) (Fig. 2b). Therefore, these SpL201 cells are capable of migrating as well
and as speedily as neural crest cells.
Chemoattraction Assays
We looked for chemotactic response in SpL201 cells by culturing them in chemotaxis
chambers in the presence of GDNF, NRG1, NGF and EGF (Fig. 3). In these experiments
SpL201 cells were plated on the upper side of a chemotatic (Millipore) chamber with 200
ng/ml of neurotrophins in the lower chamber. After 5 h of culture cells on the bottom side of
the filter were counted (Fig. 3a). We observed that the SpL201 cells were strongly attracted
(300% more, P < 0.001 T-test) to the wells where GDNF, NRG1 and EGF were present,
while NGF did not have any effect on their migratory choice compared with control
conditions (Fig. 3b).
To corroborate these findings we tested the same neurotrophins in a different assay. Here we
exposed Schwann cell precursor SpL201 cells to a neurotrophin gradient in Zigmond like
chambers [24] and then live imaged cell movements for 3 h (Fig. 4a). We found as with the
chemotactic chambers, that SpL201 cells preferentially migrated towards GNDF and NRG1.
In these experiments SpL201 cells showed a significant displacement toward the reservoir
with GDNF (P < 0.05), although NRG1 did not give a statistically significant displacement
compared with control (Fig. 4b). We used MIF (macrophage inhibitory factor) as a positive
control since it is known to stimulate cell motility [25].
These results strongly suggested that GDNF and NRG1 were possible chemoattractant
candidates for Schwann cell precursor line SpL201. We further tested this hypothesis by
culturing these cells on top of surfaces coated with the neurotrophins as part of the substrate
in a modified choice assay. This approach has been used successfully to analyze growth
cone guidance and neural crest cell migration [26, 27]. This second assay consisted of
exposing actively migrating cells to a microchip coated with neurotrophins to determine if
they steer from their course and migrate preferentially towards the surfaces where the
chemoattractant is present (Fig. 5a). The significance of this experiment stems from its
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advantage in distinguishing between cell chemoattraction (positive directional response
towards a specific molecule) from cell chemotaxis (how dynamically a cell moves
irrespective of its environment). Under these conditions cells are not exposed to a molecular
gradient, but to a specific substrate. If cells show a preferential migration over the substrate
when they encounter it (in this case as a part of the matrix over which they are growing, not
in solution in the media) by having a strong tendency to remain within the channels carrying
a particular neurotrophin, it will strongly suggest that they are attracted to it.
When we grew SpL201 on such microchips surfaces coated with neurotrophins we found
that within 5 h of plating the Schwann cell precursor cell line preferentially moved over the
lanes in the microchips that were coated with GDNF, and to a lesser degree to NRG1 lanes
(Fig. 5a–c). Meanwhile, SpL201 cultured on top of NGF or EGF did not show any
preferential attachment within the first 5 h (Fig. 5d, f). After 24 h of culture the SpL201 cells
remained preferentially on top of the lanes that have GDNF and NRG1 (Fig. 6e, f) compared
with control (Fig. 6d). We observed these results in 5/6 separate experiments. The data for
NGF and EGF was not as conclusive: although there was no preferential response within the
first 5 h of culture, next day we observed that SpL201 have moved over to the lanes with
EGF or NGF in 3/6 experiments (data not shown). Fibronectin was used as a positive control
and showed a strong positive effect on the SpL201 cells as expected for this extracellular
matrix protein (Fig. 5e).
Altogether these experiments strongly support a chemoattractive role of GDNF and NRG1
for the Schwann cell precursor SpL201 cells. The results with EGF were not conclusive
since soluble EGF attracted SpL201 (Fig. 2b) whereas EGF as a substrate was not capable of
making the cells preferentially choose it over a Fibronectin substrate (Fig. 4d). We are
planning to further test EGF in Ibidi chamber assays. NGF however, did not elicit a positive
response in these cells in both assays.
Migration Assays
Because we are working with developing cells that are physiologically sensitive to
neurotrophins, the first step towards determining that a certain molecule is a true
chemoattractant during Schwann cell migration is to be able to distinguish cell migration
towards a source/point (chemoattraction response), from enhanced cell migration
(chemotaxis response) and from cell survival or survival/proliferation (trophic response). In
the first assays we looked at simple chemoattractant response. In the next experiment we
approached this complex problem of distinguishing cell motility with techniques commonly
used to test if a specific molecule has a chemotactic effect on cells [28].
We performed classic wound assays with these cells to determine if they were capable of
moving faster in the presence of soluble forms of these neurotrophins compared with control
conditions. We observed that indeed GDNF, NRG1 and NGF were capable of enhancing the
motility of the SpL201 cells after 5 h of wounding (Fig. 7). We used Slit2 as a positive
control since it stimulates the motility of neural crest cells [29]. However, we did not find
any change in SpL201 motility in the presence of EGF. We observed that the migratory
response of these cells was strongly dependent on the absence of FBS in the media. We
found that these cells will not increase their motility if serum was present in the media
during the wound healing experiment, suggesting that already other factors present in the
serum are also capable of enhancing their motility.
Discussion
Schwann cell precursor’s cells, derive from the neural crest and are an interesting population
due to their intermediary phenotype: not fully differentiated into mature peripheral glia,
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neither a stem cell as the neural crest; not as motile as crest cells themselves, neither as slow
as its mature form. In this study we looked at the effect that GDNF, NRG1, EGF and NGF
have on the guidance and motility of these cells. Our findings shows for the first time that
GDNF and NRG1 are potent chemoattractants for a Schwann cell precursor cell line
(SpL201) and that GDNF, NRG1 and NGF are potent migratory stimulants of these cells.
Cell migration is a complex phenomenon. Cells need to re-arrange their cytoskeleton,
become polarized if they are responding to a guidance molecule, make adequate plasma
membrane protrusions and simultaneously generate traction and retraction of the cell body.
SCPs are known to migrate along developing nerves [30, 31] during the time when
neurotrophins have been shown to be key players: they are expressed early during
development and their absence causes disruption of axonal pathfinding or glial development
[32–34]. Neurotrophin signaling still remains a very complex one because it is involved in
mechanisms as distinct as the regulation of cell migration, cell proliferation, cell survival,
and chemotaxis [35, 36]. Research in the past 10 years has shown that NGF, NRG1 and
GDNF both stimulate the motility and attract Schwann cells [37–41].
In summary: we know that NRG1, NGF and NT-3 are proven chemoattractants for mature
Schwann cells. However, we do not know if these any molecules can have similar effects on
SCPs themselves. Our findings that: (a) GDNF and NRG1 attract a Schwann cell precursor
cell line and (b) that GDNF, NRG1 and NGF stimulated the motility of these cells as well,
suggest that these molecules might be also guidance and chemokinetic molecules for
embryonic precursors of Schwann cells. These results for a SCP cell line are underscored by
preliminary data from our lab where we found that Schwann cell lines (SC1.17 and SW10)
respond in a similar manner as SpL201 cells to the same neurotrophins by enhancing their
motility, while NRG1 and GDNF will not stimulate the motility of the progenitor cells, the
neural crest (data not shown).
GDNF was a strong chemoattractant candidate being the ligand for the GFRa1, NCAM and
ret receptor; the last two are expressed by Schwann cells [38]. GNDF has been shown to
enhance the motility and attract olfactory ensheathing glia [28]. Furthermore, mutations in
the ligand or receptor cause severe deficits in the neural crest derived enteric nervous system
and glia: enteric Schwann cells are not found in the gut, not from lack of trophic signals but
from lack of proper guidance signals [42, 43]. NRG1 whose erbB2/erbB3 family receptors
are known to be crucial in Schwann cell development was another good candidate: Mice
mutant for the erbB3 lacked proper Schwann cell precursor establishment [16, 44–47].
In our current study we found that GDNF and NRG1 are potent chemoattractants for the
Schwann cell precursor SpL201 suggesting that it may also be a chemoattractant for
developing SCPs as it is for mature Schwann cells. Recent studies have shown that the
proliferative effects that erbB receptors have on Schwann cells can be separated from its
effect on migration [14]. In our present study we found that NRG1 was also capable of
stimulating SpL201 motility underscoring those genetic findings with our in vitro live assays
and suggesting that NRG1 as GDNF may play a role in guiding Schwann cell precursors
towards their targets.
Our preliminary results indicate that there was no preferential migration towards a source of
NGF by the Schwann cell precursor SpL201 line in our chemotaxis assays or as in our
substrate choice assay. However, we did observe that the SpL201 cells moved more rapidly
in the presence of NGF in our wound assays, suggesting that NGF may stimulate cell
motility while it did not show to be a chemoattractant for this precursor cell line in two of
our assays, as it has already been reported for mature Schwann cells [39, 40]. This is an
interesting finding because it is known that Schwann cells are attracted to NGF as well as
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growth cones [39, 40, 48]. Our observation that SpL201 were not attracted to NGF, although
they do respond to this molecule suggests that NGF may not play the same role during SCPs
migration as for growth cones. However, because the concentration of NGF in the wounds
assays was 200 ng/ml and at these high concentrations we are stimulating the p75 low
affinity receptor, suggests that the enhanced motility of SpL201 is mediated by p75 NGF
receptor.
In summary our results show that NRG and GDNF are chemoattractants and chemokinesis
molecules for a Schwann cell precursor line (SpL201). This is the first time that some type
of Schwann cell precursor is shown to respond to neurotrophins as guidance molecules and
therefore supports a hypothetical role for these molecules in the developing peripheral
nervous system, especially the enteric one. Finally our results stress the importance of
looking more deeply into the role of neurotrophins as chemotactic molecules in Schwann
cell precursors as well as mature cells.
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Fig. 1.
SpL201 Schwann cell precursor line expresses different glia markers. SpL201 were cultured
for one day before fixing and staining for different glia markers. All wells were
counterstained with DAPI (blue) to visualize cell nuclei. a Not all SpL201 express nuclear
Sox10 transcription factor (red arrows point to double labeled cells seen as purple, while
blue arrows point to cells not positive for Sox10). b All SpL201 express RIP to some extent
(green signal) while not all express S100 (red) marker of glial cell (blue arrows point to
cells negative for S100). c Most of the SpL201 expressed high levels of neural crest/
Schwann cell marker p75 NGF receptor (red). d Not all the SpL201 expressed high levels of
GFAP, but all cells expressed it some levels of GFAP (white arrow)
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Fig. 2.
SpL201 cells migrate along neural crest cells pathways. SpL201 mouse Schwann cells were
DiI labeled and injected in HH15 chicken embryo for 24 h. DiI-positive cells were found
along the ventromedial pathway (arrow a), the dorsal aorta (arrow b), entering the gut
(arrow c) and dorsomedial pathway (arrow d). SpL201 are in red fluorescent, neural crest
cells in green fluorescence for HNK1 and cell nuclei in blue for DAPI. NT + neural tube, Nc
= notochord, DA = dorsal aorta, DRG = dorsal root ganglion and DM = dermomyotome
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Fig. 3.
GDNF, NRG1 and EGF attract Schwann cell precursors SpL201t cells. a Cartoon of the
chemotaxis experiments: cells (125,000 cells per well) were cultured for 5 h on top of
fibronectin coated chemotaxis transwells with neurotrophins present in the lower chamber
(200 ng/ml). After 5 h cells on the upper filter are removed and lower ones counted. b
Shows a graph that combines results from 4 experiments as percentage of cells that migrated
towards neurotrophins (±SEM). Compared with control conditions. The number of cells in
the wells containing GDNF, NRG1 and EGF was more than double the amount in the wells
without them or with NGF (P < 0.03 for GDNF, P < 0.008 for NRG1 and EGF)
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Fig. 4.
GDNF and NRG1 attract a Schwann cell precursor line SpL201 cells. a cartoon describing
the steps and method of the Ibidi chamber assay. b SpL201 cells were cultured overnight in
ibidi μ-slide chemotaxis chambers while an applied linear NTF gradient could be established
in media containing 2.5% FBS. The following day the cells were filmed live in the chamber
with time-lapse imaging at 90s intervals for 3 h at 37°C. The starting and end positions of
numerous cells on the side of the channel closest to the NTF source were recorded.
Displacement of each cell along the axis parallel to the gradient was then derived and the
average for all cells measured for one chamber was treated as a statistical replicate. Higher
displacement values reflect greater movement toward the NTF source, n = 5 experiments.
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CONT = 100 cells tracked, MIF = 78 cells, GDNF = 73 cells and NRG1 = 106 cells. Error
bars refer to the SEM. ANOVA with Dunnett’s post-hoc test showed that MIF and GDNF
were significantly different than the control treatment (P < 0.01 and P < 0.05 respectively)
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Fig. 5.
GDNF and NRG1 are preferential substrates for Schwann cell precursor line SpL201. a
cartoon describing the microchip arrangement. b SpL201 cells were plated on top of micro-
chips coated area (~5–7 ml) as a cell suspension in fibronectin solution, after 2 h to allow
cell attachment cultures were fully covered with culture media (DMEM, 10% FBS) and
photographed after a total of 5 h post plating. SpL201 preferentially grew over/towards
GDNF and NRG1 over this period of time (arrows). EGF and NGF did not elicit such a
rapid response. Fibronectin micro-chip lanes were used as control
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Fig. 6.
GDNF and NRG1 are preferential substrates for Schwann cell precursor line SpL201.
SpL201 cells were plated on top of microchips coated area (~5–7 ml) as a cell suspension in
fibronectin solution, after 2 h to allow cell attachment cultures were fully covered with
culture media (DMEM, 10% FBS) and photographed after a total of 5 or 24 h post plating.
SpL201 preferentially grew and remained over GDNF and NRG1 substrates over this period
of time. GDNF panel in Fig. 5b is from the same experiment as panel B in Fig. 6. NRG1
panels correspond to two different experiments
Cornejo et al. Page 16
Neurochem Res. Author manuscript; available in PMC 2012 March 12.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Fig. 7.
Neurotrophins stimulate migration of Schwann cells. SpL201 mouse Schwann cells were
plated on fibronectin coated tissue culture dishes and the following day the cell monolayer
was wounded with a pipette tip. Wounds were stopped after 5 h. Cultures were done in the
presence (+FBS, 5%) or absence (−FBS) of fetal bovine serum (FBS). Chart shows results
for all combined experiments (N = 5) done with duplicates, error bars are standard
deviation. NRG1, NGF and GDNF all stimulated the motility of SpL201 in the absence of
serum. Slit2 was used as a positive control as conditioned media from 293HEK secreting
Slit2 cells
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